_id
6921ff99b93c8af7a393387d
Ticker
OACCU
Name
Oaktree Acquisition Corp. III Life Sciences Unit
Exchange
NASDAQ
Address
333 South Grand Avenue, Los Angeles, CA, United States, 90071
Country
USA
Sector
Financial Services
Industry
Shell Companies
Currency
USD
Website
https://www.oaktreeacquisitioncorp.com/oac-iii
Description
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
Last Close
10.71
Volume
-
Current Price
10.71
Change
0
Last Updated
2026-01-05T11:57:48.827Z
Image
https://logo.clearbit.com/www.oaktreeacquisitioncorp.com
Ipo Date
2024-10-24T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
225579
Operating Income
-225579
Interest Expense
-
Pretax Income
1966742
Net Income
1966742
Eps
0.10243965983904707
Dividends Per Share
4247746
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-225579
Operating Margin
-
Total Other Income Expense Net
2192321
Cash
1328841
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
1480874
Property Plant Equipment
-
Total Assets
201249963
Payables
414107
Short Term Debt
-
Long Term Debt
-
Total Liabilities
8245536
Equity
-6764662
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
169061
Cash From Operations
-56518
Capital Expenditures
3
Cash From Investing
191990290
Cash From Financing
-193437021
Net Change In Cash
-56518
Cf_currency_symbol
USD
PE
-
PB
-30.39643378930093
ROE
-29.073765991560258
ROA
0.9772632852608275
FCF
-56521
Fcf Percent
-
Piotroski FScore
1
Health Score
38
Deep Value Investing Score
3
Defensive Investing Score
7.5
Dividend Investing Score
2
Economic Moat Investing Score
7.3
Garp Investing Score
3
Growth Investing Score
3
Momentum Investing Score
4
Net Net Investing Score
0
Quality Investing Score
3
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
225579
Quarters > 0 > income Statement > operating Income
-225579
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
1966742
Quarters > 0 > income Statement > net Income
1966742
Quarters > 0 > income Statement > eps
0.10243965983904707
Quarters > 0 > income Statement > dividends Per Share
4247746
Quarters > 0 > income Statement > shares Outstanding
19199029
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-225579
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
2192321
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1328841
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1480874
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
201249963
Quarters > 0 > balance Sheet > payables
414107
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
8245536
Quarters > 0 > balance Sheet > equity
-6764662
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
1966742
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
169061
Quarters > 0 > cash Flow > cash From Operations
-56518
Quarters > 0 > cash Flow > capital Expenditures
3
Quarters > 0 > cash Flow > cash From Investing
191990290
Quarters > 0 > cash Flow > cash From Financing
-193437021
Quarters > 0 > cash Flow > net Change In Cash
-56518
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
0.10243965983904707
Quarters > 0 > ratios > PB
-30.39643378930093
Quarters > 0 > ratios > ROE
-29.073765991560258
Quarters > 0 > ratios > ROA
0.9772632852608275
Quarters > 0 > ratios > FCF
-56521
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
269810
Quarters > 1 > income Statement > operating Income
-269810
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
1874343
Quarters > 1 > income Statement > net Income
1874343
Quarters > 1 > income Statement > eps
0.0762462144214191
Quarters > 1 > income Statement > dividends Per Share
4247746
Quarters > 1 > income Statement > shares Outstanding
24582768
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-269810
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
2144153
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
1385359
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1561142
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
199175668
Quarters > 1 > balance Sheet > payables
381554
Quarters > 1 > balance Sheet > short Term Debt
11824
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
8137983
Quarters > 1 > balance Sheet > equity
191037685
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
2153332
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-214024
Quarters > 1 > cash Flow > cash From Operations
-131998
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
250000
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
28315
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
0.0762462144214191
Quarters > 1 > ratios > PB
1.3781649692834166
Quarters > 1 > ratios > ROE
0.9811378315226129
Quarters > 1 > ratios > ROA
0.9410501889216709
Quarters > 1 > ratios > FCF
-131998
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
59
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
444802
Quarters > 2 > income Statement > operating Income
-444802
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
1658791
Quarters > 2 > income Statement > net Income
1658791
Quarters > 2 > income Statement > eps
0.06747779582836237
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
24582768
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
1658791
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
2103593
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1281483
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1482462
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
197240594
Quarters > 2 > balance Sheet > payables
395686
Quarters > 2 > balance Sheet > short Term Debt
11824
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
8077252
Quarters > 2 > balance Sheet > equity
189163342
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
1658791
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
369241
Quarters > 2 > cash Flow > cash From Operations
-75561
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-75561
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.06747779582836237
Quarters > 2 > ratios > PB
1.3918206482099478
Quarters > 2 > ratios > ROE
0.8769093326760954
Quarters > 2 > ratios > ROA
0.8409987854731364
Quarters > 2 > ratios > FCF
-75561
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
59
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
303711
Quarters > 3 > income Statement > operating Income
-303711
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
1379802
Quarters > 3 > income Statement > net Income
1379802
Quarters > 3 > income Statement > eps
0.05612882975586801
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
24582768
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-303711
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
1683513
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1357044
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1558325
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
195250622
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
11824
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
7746071
Quarters > 3 > balance Sheet > equity
187504551
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
1379802
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
214024
Quarters > 3 > cash Flow > cash From Operations
-89687
Quarters > 3 > cash Flow > capital Expenditures
3
Quarters > 3 > cash Flow > cash From Investing
-191990290
Quarters > 3 > cash Flow > cash From Financing
193437021
Quarters > 3 > cash Flow > net Change In Cash
1357044
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
0.05612882975586801
Quarters > 3 > ratios > PB
1.404133627028605
Quarters > 3 > ratios > ROE
0.7358765388046501
Quarters > 3 > ratios > ROA
0.7066825118744051
Quarters > 3 > ratios > FCF
-89690
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
58
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
703.61
Annuals > 0 > income Statement > operating Income
-703
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
2663
Annuals > 0 > income Statement > net Income
2663
Annuals > 0 > income Statement > eps
0.00010832791490364307
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
24582768
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
3367
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
1357044
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1558325
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
195250622
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
11824
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
7746071
Annuals > 0 > balance Sheet > equity
187504551
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
2663
Annuals > 0 > cash Flow > depreciation
703.61
Annuals > 0 > cash Flow > change In Working Capital
-629
Annuals > 0 > cash Flow > cash From Operations
-89687
Annuals > 0 > cash Flow > capital Expenditures
3
Annuals > 0 > cash Flow > cash From Investing
-191990290
Annuals > 0 > cash Flow > cash From Financing
193437021
Annuals > 0 > cash Flow > net Change In Cash
1357044
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
0.00010832791490364307
Annuals > 0 > ratios > PB
1.404133627028605
Annuals > 0 > ratios > ROE
0.0014202321947908347
Annuals > 0 > ratios > ROA
0.0013638881006996229
Annuals > 0 > ratios > FCF
-89690
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
57
Valuation > metrics > PE
0.10243965983904707
Valuation > metrics > PB
-30.39643378930093
Valuation > final Score
70
Valuation > verdict
99.0% Undervalued
Profitability > metrics > ROE
-29.073765991560258
Profitability > metrics > ROA
132.80954355333407
Profitability > final Score
45
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-0.10289505961946266
Risk > final Score
30
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.5760660891991685
Liquidity > metrics > Quick Ratio
3.5760660891991685
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
100
Prev Valuations > 2
100
Prev Profitabilities > 0
47
Prev Profitabilities > 1
47
Prev Profitabilities > 2
46
Prev Risks > 0
59
Prev Risks > 1
80
Prev Risks > 2
59
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:12:05.240Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-13
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.08
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.08
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0.08
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-14
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.07
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.07
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2024-12-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.0561
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-10-04
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.01
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.01
Earnings History > 4 > surprise Percent
-
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AProfit Review: How volatile is Sarepta Therapeutics Inc. stock - July 2025 Market Mood & Free Verified High Yield Trade Plans baoquankhu1.vn
Read more →Signal Recap: Is Teleflex Incorporated stock influenced by commodity prices - Trade Performance Summary & Community Trade Idea Sharing baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Oaktree Acquisition Corp. III Life Sciences Unit
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.08
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.